secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-07-21T12:50:36+00:00
Accession:  0001493152-26-034018
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions completes precision testing for FDA 510(k) submission for codeine detection
--------------------------------------------------------------------------------

- Precision testing included over 1,600 tests across three production runs and three independent sites.
- Results confirmed repeatable, reproducible performance, strengthening the FDA 510(k) submission package.
- Submission targets U.S. market clearance for the Intelligent Fingerprinting Drug Screening System for opiate codeine.
- Company plans U.S. launch after FDA 510(k) clearance, citing a multi-billion-dollar annual drug screening market.
- CEO Harry Simeonidis stated the testing puts the company firmly on track for submission and launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226034018/0001493152-26-034018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226034018/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer